Receptor tyrosine kinases (RTKs) are a subclass of tyrosine kinases that are involved in mediating cell-to-cell communication and controlling a wide range of complex biological functions, including cell growth, motility, differentiation, and metabolism.
The report forecast global Receptor Tyrosine Protein Kinase Targeted Drugs market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively."
The report demonstrates detail coverage of Receptor Tyrosine Protein Kinase Targeted Drugs industry and main market trends.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares of the leading Receptor Tyrosine Protein Kinase Targeted Drugs by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global Receptor Tyrosine Protein Kinase Targeted Drugs market discussed. Overall, this report covers the historical situation, present status and the future prospects of the global Receptor Tyrosine Protein Kinase Targeted Drugs market for 2016-2026.
Moreover,the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to over 100 countries and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard,while the online market increase. Fortunately, with the development of vaccine and other effort by global governments and orgnizations, the nagetive impact of COVID-19 is excepted to subside and the global ecnomy is excepted to recover.
Studying and analyzing the impact of Coronavirus COVID-19 on the Receptor Tyrosine Protein Kinase Targeted Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Market Segment by Product Application
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Finally, the report provides detailed profile and data information analysis of leading company.
AstraZeneca Plc
ImmunoGen, Inc.
F. Hoffmann-La Roche Ltd.
AVEO Pharmaceuticals, Inc.
Hanmi Pharmaceuticals, Co. Ltd.
Etubics Corporation
Merrimack Pharmaceuticals, Inc.
GlaxoSmithKline Plc
GamaMabs Pharma S.A.
Kolltan Pharmaceuticals, Inc.
Sorrento Therapeutics, Inc.
Merus B.V.
Symphogen A/S
Sihuan Pharmaceutical Holdings Group Ltd.
Novartis AG
Takis S.r.l.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Report Includes:
- xx data tables (appendix tables)
- Overview of global Receptor Tyrosine Protein Kinase Targeted Drugs market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Receptor Tyrosine Protein Kinase Targeted Drugs market
- Profiles of major players in the industry, including AstraZeneca Plc, ImmunoGen, Inc., F. Hoffmann-La Roche Ltd., AVEO Pharmaceuticals, Inc., Hanmi Pharmaceuticals, Co. Ltd
Research Objectives
1.To study and analyze the global Receptor Tyrosine Protein Kinase Targeted Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Receptor Tyrosine Protein Kinase Targeted Drugs market by identifying its various subsegments.
3.Focuses on the key global Receptor Tyrosine Protein Kinase Targeted Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Receptor Tyrosine Protein Kinase Targeted Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Receptor Tyrosine Protein Kinase Targeted Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Receptor Tyrosine Protein Kinase Targeted Drugs Professional Survey Report Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type
2.1.1 BA-0702
2.1.2 CDX-3379
2.1.3 Elgemtumab
2.1.4 ETBX-031
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Non-Small Cell Carcinoma
2.2.2 Solid Tumor
2.2.3 Melanoma
2.2.4 Colorectal Cancer
2.2.5 Others
2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Comparison by Regions (2016-2026)
2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (2016-2026)
2.3.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2016-2026)
2.3.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2016-2026)
2.3.4 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2016-2026)
2.3.5 South America Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Receptor Tyrosine Protein Kinase Targeted Drugs Industry Impact
2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Receptor Tyrosine Protein Kinase Targeted Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer Market Share
3.5 Top 10 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
3.7 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs Industry Key Manufacturers
4.1 AstraZeneca Plc
4.1.1 Company Details
4.1.2 AstraZeneca Plc Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 AstraZeneca Plc News
4.2 ImmunoGen, Inc.
4.2.1 Company Details
4.2.2 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.2.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 ImmunoGen, Inc. News
4.3 F. Hoffmann-La Roche Ltd.
4.3.1 Company Details
4.3.2 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.3.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 F. Hoffmann-La Roche Ltd. News
4.4 AVEO Pharmaceuticals, Inc.
4.4.1 Company Details
4.4.2 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.4.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 AVEO Pharmaceuticals, Inc. News
4.5 Hanmi Pharmaceuticals, Co. Ltd.
4.5.1 Company Details
4.5.2 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.5.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Hanmi Pharmaceuticals, Co. Ltd. News
4.6 Etubics Corporation
4.6.1 Company Details
4.6.2 Etubics Corporation Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.6.3 Etubics Corporation Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Etubics Corporation News
4.7 Merrimack Pharmaceuticals, Inc.
4.7.1 Company Details
4.7.2 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.7.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Merrimack Pharmaceuticals, Inc. News
4.8 GlaxoSmithKline Plc
4.8.1 Company Details
4.8.2 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.8.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 GlaxoSmithKline Plc News
4.9 GamaMabs Pharma S.A.
4.9.1 Company Details
4.9.2 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.9.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 GamaMabs Pharma S.A. News
4.10 Kolltan Pharmaceuticals, Inc.
4.10.1 Company Details
4.10.2 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.10.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Kolltan Pharmaceuticals, Inc. News
4.11 Sorrento Therapeutics, Inc.
4.11.1 Company Details
4.11.2 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.11.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Sorrento Therapeutics, Inc. News
4.12 Merus B.V.
4.12.1 Company Details
4.12.2 Merus B.V. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.12.3 Merus B.V. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Merus B.V. News
4.13 Symphogen A/S
4.13.1 Company Details
4.13.2 Symphogen A/S Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.13.3 Symphogen A/S Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Symphogen A/S News
4.14 Sihuan Pharmaceutical Holdings Group Ltd.
4.14.1 Company Details
4.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Sihuan Pharmaceutical Holdings Group Ltd. News
4.15 Novartis AG
4.15.1 Company Details
4.15.2 Novartis AG Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.15.3 Novartis AG Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.15.4 Main Business Overview
4.15.5 Novartis AG News
4.16 Takis S.r.l.
4.16.1 Company Details
4.16.2 Takis S.r.l. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.16.3 Takis S.r.l. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.16.4 Main Business Overview
4.16.5 Takis S.r.l. News
4.17 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
4.17.1 Company Details
4.17.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification
4.17.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.17.4 Main Business Overview
4.17.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. News
5 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Categorized by Regions
5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Regions (2016-2021)
5.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Regions (2016-2021)
5.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
5.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
5.5 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
6 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Categorized by Countries
6.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Countries (2016-2021)
6.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2016-2021)
6.1.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
6.1.4 Canada Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
6.1.5 Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
6.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) by Manufacturers
6.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2016-2021)
6.4 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
7 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Categorized by Countries
7.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2016-2021)
7.1.3 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.1.4 UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.1.5 France Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.1.6 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.1.7 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.1.8 Spain Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
7.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) by Manufacturers
7.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2016-2021)
7.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
8 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Categorized by Countries
8.1 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2016-2021)
8.1.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.1.4 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.1.5 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.1.6 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.1.7 India Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
9 South America Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Categorized by Countries
9.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Countries (2016-2021)
9.1.2 South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2016-2021)
9.1.3 Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
9.2 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2016-2021)
9.3 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
10 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2016-2021)
10.1.3 GCC Countries Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
10.1.4 Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
10.1.5 Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
10.1.6 South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
10.3 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
11 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Type
11.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2016-2021)
11.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2016-2021)
11.2 BA-0702 Sales Growth Rate and Price
11.2.1 Global BA-0702 Sales Growth Rate (2016-2021)
11.2.2 Global BA-0702 Price (2016-2021)
11.3 CDX-3379 Sales Growth Rate and Price
11.3.1 Global CDX-3379 Sales Growth Rate (2016-2021)
11.3.2 Global CDX-3379 Price (2016-2021)
11.4 Elgemtumab Sales Growth Rate and Price
11.4.1 Global Elgemtumab Sales Growth Rate (2016-2021)
11.4.2 Global Elgemtumab Price (2016-2021)
11.5.1 Global ETBX-031 Sales Growth Rate (2016-2021)
11.5.2 Global ETBX-031 Price (2016-2021)
11.6 Others Sales Growth Rate and Price
11.6.1 Global Others Sales Growth Rate (2016-2021)
11.6.2 Global Others Price (2016-2021)
12 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Application
12.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2016-2021)
12.2 Non-Small Cell Carcinoma Sales Growth Rate (2016-2021)
12.3 Solid Tumor Sales Growth Rate (2016-2021)
12.4 Melanoma Sales Growth Rate (2016-2021)
12.5 Colorectal Cancer Sales Growth Rate (2016-2021)
13 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast
13.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, Sales and Growth Rate (2021-2026)
13.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Regions (2021-2026)
13.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2026)
13.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2026)
13.2.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2026)
13.2.4 South America Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2026)
13.2.5 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast (2021-2026)
13.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Type (2021-2026)
13.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2021-2026)
13.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Type (2021-2026)
13.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Forecast by Application (2021-2026)
13.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2021-2026)
13.4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share Forecast by Application (2021-2026)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Receptor Tyrosine Protein Kinase Targeted Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Type
Figure Global Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type in 2020
Figure BA-0702 Picture
Figure CDX-3379 Picture
Figure Elgemtumab Picture
Figure ETBX-031 Picture
Figure Others Picture
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Volume) by Application
Figure Non-Small Cell Carcinoma Picture
Figure Solid Tumor Picture
Figure Melanoma Picture
Figure Colorectal Cancer Picture
Figure Others Picture
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Comparison by Regions (M USD) 2016-2026
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Million US$) (2016-2026)
Figure North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Receptor Tyrosine Protein Kinase Targeted Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Manufacturer (2016-2021)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturer in 2020
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Manufacturer (2016-2021)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Manufacturer in 2020
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market
Table Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table Mergers & Acquisitions Planning
Table AstraZeneca Plc Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of AstraZeneca Plc
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca Plc 2016-2021
Table AstraZeneca Plc Main Business
Table AstraZeneca Plc Recent Development
Table ImmunoGen, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of ImmunoGen, Inc.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ImmunoGen, Inc. 2016-2021
Table ImmunoGen, Inc. Main Business
Table ImmunoGen, Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of F. Hoffmann-La Roche Ltd.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche Ltd. 2016-2021
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table AVEO Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of AVEO Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AVEO Pharmaceuticals, Inc. 2016-2021
Table AVEO Pharmaceuticals, Inc. Main Business
Table AVEO Pharmaceuticals, Inc. Recent Development
Table Hanmi Pharmaceuticals, Co. Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Hanmi Pharmaceuticals, Co. Ltd.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hanmi Pharmaceuticals, Co. Ltd. 2016-2021
Table Hanmi Pharmaceuticals, Co. Ltd. Main Business
Table Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table Etubics Corporation Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Etubics Corporation
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Etubics Corporation 2016-2021
Table Etubics Corporation Main Business
Table Etubics Corporation Recent Development
Table Merrimack Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Merrimack Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merrimack Pharmaceuticals, Inc. 2016-2021
Table Merrimack Pharmaceuticals, Inc. Main Business
Table Merrimack Pharmaceuticals, Inc. Recent Development
Table GlaxoSmithKline Plc Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of GlaxoSmithKline Plc
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline Plc 2016-2021
Table GlaxoSmithKline Plc Main Business
Table GlaxoSmithKline Plc Recent Development
Table GamaMabs Pharma S.A. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of GamaMabs Pharma S.A.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GamaMabs Pharma S.A. 2016-2021
Table GamaMabs Pharma S.A. Main Business
Table GamaMabs Pharma S.A. Recent Development
Table Kolltan Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Kolltan Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Kolltan Pharmaceuticals, Inc. 2016-2021
Table Kolltan Pharmaceuticals, Inc. Main Business
Table Kolltan Pharmaceuticals, Inc. Recent Development
Table Sorrento Therapeutics, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Sorrento Therapeutics, Inc.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sorrento Therapeutics, Inc. 2016-2021
Table Sorrento Therapeutics, Inc. Main Business
Table Sorrento Therapeutics, Inc. Recent Development
Table Merus B.V. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Merus B.V.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merus B.V. 2016-2021
Table Merus B.V. Main Business
Table Merus B.V. Recent Development
Table Symphogen A/S Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Symphogen A/S
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Symphogen A/S 2016-2021
Table Symphogen A/S Main Business
Table Symphogen A/S Recent Development
Table Sihuan Pharmaceutical Holdings Group Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Sihuan Pharmaceutical Holdings Group Ltd.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sihuan Pharmaceutical Holdings Group Ltd. 2016-2021
Table Sihuan Pharmaceutical Holdings Group Ltd. Main Business
Table Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
Table Novartis AG Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Novartis AG
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis AG 2016-2021
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Takis S.r.l. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Takis S.r.l.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takis S.r.l. 2016-2021
Table Takis S.r.l. Main Business
Table Takis S.r.l. Recent Development
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction, Application and Specification of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2016-2021
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2016-2021)
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions (2016-2021)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Regions in 2020
Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions (2016-2021)
Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions in 2020
Figure North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2016-2021)
Figure Asia-pacific Receptor Tyrosine Protein Kinase Targeted D
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.